In short
Female infertility affects millions of women worldwide, and understanding when to seek diagnostic testing can make a significant difference in achieving successful pregnancy. Early evaluation and appropriate testing help identify the underlying causes and guide treatment decisions.
Key points
- Women under 35 should seek infertility evaluation after 12 months of trying, while those 35 and older should seek help after just six months due to age-related fertility decline.
- Ovulation problems are the leading cause of female infertility, affecting about one in four women with fertility issues, often related to conditions like polycystic ovary syndrome.
- Both partners should undergo evaluation, as infertility stems from male factors, female factors, or combined factors in approximately equal proportions.
- Diagnostic testing typically includes hormone blood tests, ovulation monitoring, imaging studies like ultrasound and hysterosalpingography, and sometimes procedures like hysteroscopy or laparoscopy.
- About 15% of couples have unexplained infertility where no specific cause is identified despite thorough testing, yet many can still achieve pregnancy with treatment.
- The complete diagnostic evaluation is usually completed within two months and includes tests timed to specific points in the menstrual cycle.
- Clinical trial participation requires comprehensive baseline testing including hormone levels, ovarian reserve assessment, and documentation of specific fertility factors.
- Women with irregular periods, known fertility conditions, or history of pelvic infections should seek evaluation immediately rather than waiting the standard timeframes.
Introduction: Who Should Undergo Diagnostics and When
Knowing when to seek diagnostic testing for infertility is crucial for couples trying to conceive. The timing of when you should consider an evaluation depends largely on your age and specific circumstances. Healthcare providers generally recommend that women under 35 years old should seek an infertility evaluation after trying to conceive for 12 months without success through regular, unprotected sexual intercourse. This timeframe is based on research showing that approximately 85% of women will conceive within the first year of trying.
For women aged 35 to 40 years, the recommendation changes significantly. Because fertility declines with age, these women should consider seeking help after just six months of unsuccessful attempts to conceive. The reason for this shorter waiting period is that female fecundability—the probability of achieving pregnancy in one menstrual cycle—decreases as women age, and timing becomes more critical for successful outcomes.
Women over 40 years old should consider immediate evaluation and may benefit from testing or treatment right away, without waiting for months of trying. This is because by age 40, the chance of pregnancy per menstrual cycle drops to only about 5%, and aging eggs become less viable.
There are also specific situations where seeking help sooner makes sense, regardless of age. If you or your partner have known fertility problems, a history of irregular or painful periods, pelvic inflammatory disease (an infection of the upper female genital tract), repeated miscarriages, previous cancer treatment, or endometriosis (a condition where tissue similar to the lining of the womb grows outside the uterus), your doctor might recommend beginning testing or treatment right away. Women with absent or very irregular menstrual cycles should also seek help immediately, as these can indicate problems with ovulation.
Understanding these timeframes helps couples make informed decisions about when to seek help. Waiting too long to begin diagnostic testing can sometimes mean missing opportunities for successful treatment, particularly as age-related fertility decline progresses. At the same time, both partners should be evaluated, as infertility can stem from male factors, female factors, or a combination of both in approximately equal proportions.
Diagnostic Methods for Identifying Female Infertility
When you visit a healthcare provider for infertility concerns, they will begin with a comprehensive approach to understand what might be preventing pregnancy. The diagnostic process typically starts with taking a detailed medical history and conducting a physical examination of both partners. This initial step helps identify potential risk factors and guides which specific tests might be most helpful.
Ovulation Testing
Since problems with ovulation account for approximately 25% of female infertility cases, testing to confirm whether you are releasing eggs regularly is often one of the first steps. An at-home, over-the-counter ovulation prediction kit can detect the surge in luteinizing hormone that occurs before ovulation. These kits are simple to use and help determine if and when ovulation is happening.
Your doctor may also order blood tests to measure progesterone, a hormone produced after ovulation. Finding progesterone in your blood confirms that you have ovulated during that cycle. Additional hormone testing may check levels of other hormones that control reproductive processes, including follicle-stimulating hormone, which helps eggs mature in the ovaries, and prolactin, a hormone that when elevated can interfere with ovulation.
Ovarian Reserve Testing
This type of testing helps determine the quality and quantity of eggs available for ovulation. Women at risk of having a depleted egg supply, particularly those older than 35, might undergo this series of blood and imaging tests. The testing evaluates how well your ovaries are functioning and how many viable eggs remain. This information is valuable because you are born with all the eggs you will ever have, and this supply can run out earlier than expected, sometimes before the natural age of menopause.
Hysterosalpingography
Hysterosalpingography is a specialized X-ray examination of the uterus and fallopian tubes. During this procedure, a contrast dye is injected into your uterus through the cervix, and X-ray images are taken. The dye shows up on the X-rays, allowing doctors to see the shape of your uterine cavity and check whether the fallopian tubes are open or blocked. The test can identify problems inside the uterus and determine if fluid can pass through the fallopian tubes properly. If any problems are found, you will likely need further evaluation.
Blocked or scarred fallopian tubes are a common cause of infertility, often resulting from pelvic inflammatory disease, which can be caused by untreated sexually transmitted infections like chlamydia and gonorrhea. Problems with the fallopian tubes account for approximately 11% of female infertility cases.
Ultrasound Imaging
A pelvic ultrasound uses sound waves to create images of your reproductive organs. This test can look for uterine or fallopian tube disease without using radiation. Sometimes a special type of ultrasound called a sonohysterogram or saline infusion sonogram is performed. During this test, sterile salt water is placed into the uterus through the cervix, which helps doctors see details inside the uterus that might not be visible on a regular ultrasound.
Hysteroscopy
Hysteroscopy involves inserting a thin, lighted telescope-like device through your cervix into your uterus. This allows your doctor to directly view the inside of the uterine cavity and look for abnormalities such as polyps (small growths), fibroids (non-cancerous tumors), or adhesions (scar tissue). These conditions can affect the ability of a fertilized egg to implant in the uterus. The procedure can sometimes be both diagnostic and therapeutic, meaning doctors can treat certain problems during the same procedure.
Laparoscopy
In some cases, your doctor might recommend laparoscopy, a minimally invasive surgical procedure. A small incision is made near your navel, and a thin viewing instrument is inserted to examine your ovaries, fallopian tubes, and uterus. This procedure is particularly useful for identifying conditions like endometriosis, which affects approximately 15% of infertile couples and can cause scarring of the fallopian tubes. Laparoscopy can also detect pelvic adhesions and other abnormalities that might not show up on other imaging tests.
Genetic and Additional Testing
Depending on your situation, your doctor might recommend genetic testing to identify whether a genetic defect could be contributing to infertility. Some chromosomal abnormalities can affect egg quality or the ability to carry a pregnancy. Thyroid function tests may also be performed, as both an overactive and underactive thyroid gland can prevent ovulation and affect fertility.
The diagnostic process is usually completed within about two months once evaluation begins. Your healthcare team will use the results from these various tests to understand the specific factors affecting your fertility and develop an appropriate treatment plan. In approximately 15% of couples, no specific cause can be identified despite thorough testing, a situation called unexplained infertility.
Diagnostics for Clinical Trial Qualification
When considering participation in clinical trials for infertility treatments, specific diagnostic tests serve as standard criteria for determining eligibility. Clinical trials are research studies that test new treatments or procedures, and they often have strict requirements about which patients can participate. These requirements help ensure the safety of participants and the reliability of study results.
The qualification process typically begins with confirming the diagnosis of infertility through the standard criteria: inability to conceive after 12 months of regular unprotected intercourse for women under 35, or after six months for women 35 and older. This baseline definition ensures that participants truly meet the medical criteria for infertility.
Clinical trials often require comprehensive hormone testing to establish baseline reproductive function. This includes measuring levels of follicle-stimulating hormone, luteinizing hormone, estrogen, progesterone, and other reproductive hormones. These tests help researchers understand each participant's hormonal profile and ensure that the study population is appropriate for the intervention being tested.
Ovarian reserve testing is frequently required for clinical trial participation, especially for trials involving fertility treatments or procedures. Blood tests measuring anti-Müllerian hormone and imaging tests evaluating ovarian follicle count help determine the quantity and quality of eggs available. This information is crucial for predicting how participants might respond to fertility treatments and for stratifying participants into appropriate study groups.
Documentation of tubal patency—meaning the fallopian tubes are open and not blocked—is often necessary for trials involving treatments that require functioning tubes, such as intrauterine insemination studies. This is typically confirmed through hysterosalpingography or other imaging techniques. Conversely, trials for in vitro fertilization may not require this specific test, as the procedure bypasses the fallopian tubes entirely.
Uterine evaluation through imaging or hysteroscopy may be required to confirm normal uterine anatomy or to rule out conditions that might affect study outcomes. Trials testing treatments for specific conditions, such as polycystic ovary syndrome or endometriosis, require confirmed diagnosis of these conditions through appropriate diagnostic criteria.
Male partner evaluation is typically also required, even in trials focusing on female infertility treatments. This ensures that any fertility issues stem primarily from female factors or helps stratify couples based on whether both partners have contributing factors. A semen analysis is the standard test used to evaluate male fertility.
Genetic screening may be required for some clinical trials, particularly those involving advanced reproductive technologies. This testing can identify chromosomal abnormalities or genetic conditions that might affect treatment outcomes or pregnancy success. Some trials may exclude participants with certain genetic findings, while others may specifically study treatments for genetic causes of infertility.
Health screening tests beyond reproductive function are also common requirements. These may include general health assessments, screening for infectious diseases, and tests to ensure participants are healthy enough to undergo the proposed treatments safely. Understanding and completing all required diagnostic testing is an important part of the clinical trial enrollment process and helps protect participant safety while ensuring meaningful research results.
